Skip to content
DefDex

Federal award

ANTIRADICAL THERAPEUTICS LLC

W81XWH19C0022

ContractSBIR/STTR SR2

Obligated and Ceiling

Obligated (net)
$942,513.53
Ceiling (potential value, not spending)
$942,513.53
Current value
$942,513.53
Gross positive obligations
$1,234,126.74

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
ANTIRADICAL THERAPEUTICS LLC · X9QNA95VGLP8
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
ANTIRADICAL THERAPEUTICS LLC · X9QNA95VGLP8
Awarding agency
Department of War · sub-agency 2100 · office W81XWH
Funding agency
Department of War · sub-agency 2100
Product or service (PSC)
AN91 · R&D- MEDICAL: OTHER (BASIC RESEARCH)
Industry (NAICS)
541715 · RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PIID
W81XWH19C0022
Award type code
D
Actions
6 · Dec 3, 2018 to Sep 1, 2022
Why it is listed
gross positive obligations of $100k or more (contracts); SBIR/STTR award

Open this award on USAspending →

Action History6

Award actions
DateFYModAction typeObligationCompany in company totals
Sep 1, 2022FY2022P00005B$234,310.02
—
Aug 23, 2022FY2022P00004B−$291,613.21
—
Oct 19, 2020FY2021P00003F$0.00
—
Jan 18, 2019FY2019P00002D$0.00
—
Dec 19, 2018FY2019P00001M$0.00
—
Dec 3, 2018FY20190—$999,816.72
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.